Therapy Market Research Reports & Industry Analysis

... Proton Therapy Market Opportunity Analysis” Report Highlight: US Proton Therapy Market Overview Targeted Patient Base & Economic Capacity Analysis Proton Therapy Cost Analysis Proton Therapy Reimbursement Policy Proton Therapy Center Infrastructure Analysis US Proton Therapy Market ...

Peptide Therapeutics Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary Peptide Therapeutics Pipeline Database provides online access to Peptide Therapeutics on the market and in research & development. The peptide segment database contains about 900 files. Each ...

... a comprehensive assessment of the fast–evolving, high–growth of United States Pain Management Therapeutics Sector. This 73 page report with 46 Figures and ... the basis of: I. United States Pain Management Therapeutics Market from the year 2005 – 2018 II. United States Pain Management Patients Population from ...

... ? Multiple Sclerosis – Oral therapy takes centre stage is a comprehensive Therapy Trends report packed with knowledgeable opinions and insights of 12 leading US and European KOLs on current ... , MD, is a preeminent MS clinician at the Corinne Goldsmith Dickinson Center for Multiple Sclerosis, Co-Director, Multiple Sclerosis Care Center, Maimonides Medical Center Dr Robert Naismith, MD, Assistant Professor ...

... Gene Therapy to Cancer Treatment Gene Therapy Market Dynamics: Drivers, Challenges & Future Outlook FDA & AMA Guidelines for Gene Therapy Gene Therapy Pipeline by Phase, Indications, Country & Company Gene Therapy Pipeline: 246 Drugs Marketed Gene Therapy: 2 (Gendicine & Rexin-G) Cancer Gene Therapy Pipeline ...

... can be prevented. “UAE IVF Treatment Market Outlook 2018” Report Highlights: Current Market Scenario IVF Treatment Market Potential Treatment cycle & Birth Rate Fertility Treatment Loan Facility Regulations for Licensing of Fertilization Centers Medical ...

... make it more accessible to patients. According to the “US Proton Therapy Outlook: Market Opportunities”, by RNCOS, the United States will be home to almost 29 such centers ... size and its future condition. After a thorough analysis of the market, RNCOS has deduced various trends, drivers and challenges which ...

... benefit/positioning and support patient initiatives. Payer Insights: Hepatitis C, based on in-depth interviews with 12 leading healthcare payers in the US, is packed with hard-hitting, candid ... been matched by the opposition of healthcare payers at the cost. This report gives insights into what US healthcare payers really think about HCV drug ...

... . “Recombinant Therapeutic Proteins Market & Pipeline Analysis” Report Highlights: Global Market Overview Mechanisms of Recombinant Protein Production Types of Recombinant DNA Technology Clinical Pipeline by Phase, Indication, Company, & Country Marketed Recombinant Therapeutic Protein Drugs ...

The report titled “Global Antifungal Therapeutics Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of global antifungal therapeutics market with focus on antifungal drug classes – Polyenes, Azoles, Echinocandins and ... , various antifungal agents with novel action mechanisms, broader action spectrum and fewer side effects have emerged. Growth within global antifungal therapeutics market is driven ...

'2014 Market Research Report on Global Radiotherapy Simulator Machine Industry' was a professional and depth research report on Global Radiotherapy Simulator Machine industry that you would know the world's major regional market conditions of Radiotherapy Simulator Machine industry, the main region including ...

... neurologists to ascertain how practising physicians currently view and evaluate the gene therapy development space. Specifically we are asking them... How familiar they are with ... What they perceive to be the key benefits of gene therapy? What are their specific concerns with gene therapy? What is the highest ...

... a biologic therapy? Whether, and to what extent, quality-of-life measures will be more important than secondary efficacy measures for differentiating new biologic therapies for severe asthma? What level of advantage, if any, reduced dosing frequency would provide for a biologic severe asthma ...

... centers that have been established globally. According to our report, “Global Proton Therapy Outlook 2018”, 16 such centers have been established ... capacity of existing centers and those that are expected to come up by 2018. In the Geographic Assessment section, we have provided a detailed analysis of four ...

... titled “Global Aortic Aneurysm Market: Trends and Opportunities (2014-2019)” provides an in-depth analysis of global aortic aneurysm repair market with major focus on more prevalent endovascular abdominal aortic aneurysm repair. The report also provides detailed analysis of aortic aneurysm market in major regions ...

... for more proton therapy centers are very high. This report is divided into 14 Chapters A. United States Proton Therapy Market – Actual ... IBA Proton Therapy 2. Optivus Proton Therapy 3. Hitachi Proton Therapy 4. Mevion Proton Therapy 5. Varian Proton Therapy Chapter No. 11 speaks of Proton Therapy centers ...

... threatening diseases. “Global Cell Therapy Market & Pipeline Insight” Report Highlights & Findings: Introduction to Cell therapy Global Cell Therapy Market Overview Global Cell Therapy Market Dynamics Cell Therapy Pipeline by Phase, Country & Target Indications Cell Therapy Drugs in Pipeline: More ...

... and in industry. Since discovery, RNA interference is considered to be a turning point for molecular ... Global RNAi Therapy Report Highlights: Introduction & Need Analysis of RNAi Therapy Benefits & Drug Delivery Mechanics Related to RNAi RNAi Therapy Market Insight Ongoing Clinical Trail/Pipeline for RNAi ...

There are more than 1400 sustained or controlled release drugs have been approved all over the world. Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contribution of generics is approximately 20% of overall ...

Over the last decades, therapeutic options for Plaque Psoriasis (PsO) and Psoriatic Arthritis (PsA) have expanded ... OTEZLA – apremilast, Xeljanz – tofacitinib) and onwards. In this report, we highlight the novel targets – oral, injectables, and topical drugs in the pipeline for the treatment of Psoriasis ...

... decade, Proteasome inhibitor, Velcade (bortezomib) and the immunomodulatory drugs – Thalomid (thalidomide) and Revlimid (lenalidomide) have become the cornerstone of treatment for patients with Multiple Myeloma (MM) resulting ...

... map for biosimilars space, at this time we see Sandoz, JCR, Meiji Seika Pharma, Fuji Film Kyowa Kirin Biologics, Nippon Kayaku, Nichi Iko, Yoshindo etc. to be amongst the key players in biogenerics business in Japan. It is also noteworthy ...

... infections during the treatment were not available. If that fails, the gains ... super infections” warranting need for new classes of antibiotics and other preventive/therapeutic approaches ... Gram Negative infections and CRE. Pipeline of novel targets being used to develop new drugs to treat infections and resistance ...

... bigger for newer options than late stage if they succeed.In coming years, we expect second generation antiandrogens (Androgen synthesis inhibitors/Androgen receptor inhibitors, Xtandi, ARN-509, ODM-021, Zytiga, TAK-700, TOK-001) to replace ...

... in the pre-clinical studies. There are many applications of the peptide drugs. The most popular and dominant segments include cancer ... demand for peptide drugs, this market is expected to grow at a CAGR of 9-10% to reach approximately USD 27.3 billion by 2018. “Global Peptide Therapeutics Market & Pipeline ...

... lymphocytic/lymphoblastic leukemia may also occur in adults. The acute lymphocytic/lymphoblastic leukemia market is segmented into two types—childhood acute lymphocytic/lymphoblastic leukemia and adult acute lymphocytic/lymphoblastic leukemia. The acute lymphocytic/lymphoblastic leukemia therapeutics market ...

... is increasing at an alarming rate. According to RNCOS’ report “Booming IVF Market in India”, the IVF market is poised to witness impressive CAGR of around 14% over ... region-wise i.e. their penetration across East/West/North/South India; their structure i.e. chain, independent and hospital-based; the number of ...

... IUI, IVF, and ICSI (intra cytoplasmic sperm injection). India has become one of the favored destinations for infertility treatments such as IVF due to several ... health care system. “India IVF Treatment Market Outlook 2018” report by KuicK Research gives comprehensive insight on following aspects related to booming IVF treatment market in India: Market Overview IVF Treatment Market Potential Total Fertility ...

... Scope of the report The report titled “Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)” provides an in-depth analysis of global rheumatoid arthritis market with special focus on biologics drugs. It also accesses the key opportunities and underlying trends in the market and outlines the ...

... report titled “Global Multiple Sclerosis Market: Trends & Opportunities (2013-18)“ provide an insight into the market dynamics and various trends and opportunities associated with the global multiple sclerosis market. The report ... contributor to the global multiple sclerosis market has been assessed. The report concludes with a brief discussion of major factors driving the global multiple sclerosis market and profiles major ...

... Report The report titled “Global Age-Related Macular Degeneration (AMD) Market: Trends & Opportunities (2013-2018)” provides an in-depth analysis of the global age-related macular degeneration market with detailed analysis of various ... Age-related macular degeneration (AMD) is a condition affecting older people, and involves the loss of the person's central field of vision. Several forms of AMD exist such as early AMD ...

... Xeljanz to gain approval in Europe (see ViewPoints: Key opinion leader casts doubt as to whether Pfizer's Xeljanz ... Xeljanz's ability to inhibit progression of structural disease. FirstWord polled US-based rheumatologists in May to ascertain how physicians were utilising Xeljanz and this week's Physician Views ...

... survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which could thus become the ... selective without the need for any genetic manipulation. “Global Oncolytic Virus Therapy Pipeline Analysis” by PNS Pharma gives comprehensive insight on the ...

... report titled “Global Testosterone Therapy Market”: Trends & Opportunities (2013-2018)” provides an in-depth analysis of the global Testosterone Therapy market with detailed analysis of symptoms, diagnosis and treatment of testosterone deficiency. The report majorly focuses on the US testosterone therapy market and also assesses ...

... or ribavirin, thus significantly reducing side-effect burden. A Physician Views poll run by FirstWord in December 2012 (among 74 US-based gastroenterologists ... one-tablet combination of sofosbuvir and ledipasvir). But what of its commercial opportunity in the meantime, assuming the drug is launched in ...

... babies, thus spurring the performance of this category. Euromonitor International's Food Intolerance in Hong Kong, China report tracks the developments of health-associated ... and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012 ...

... job during the review period educating their... Euromonitor International's Food Intolerance in Russia report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012, ...

... , retail value sales reached ¥13 billion in 2012. Euromonitor International's Food Intolerance in Japan report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012, ...

... fashionable to look for gluten-free or diabetic food in South Korea. Euromonitor International's Food Intolerance in South Korea report tracks the developments of health- ... and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012, ...

... widely accepted than regular baby formula, especially amongst high-income consumers. According to a company source, there is a... Euromonitor International's Food Intolerance in Venezuela report tracks the developments of health-associated product types and the healthy-option positioning of competing brands ...

... tapping the niche by introducing lactose-free... Euromonitor International's Food Intolerance in Colombia report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012 ...

... all continued educating the masses in the media. Euromonitor International's Food Intolerance in India report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012, ...

... and healthy diet was the main driver of sales within the food intolerance category in 2012. During the last years of the review ... availability of these products on the shelves of major... Euromonitor International's Food Intolerance in Spain report tracks the developments of health-associated product types ...

... downturn than other areas of health and... Euromonitor International's Food Intolerance in Portugal report tracks the developments of health-associated product types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012, ...

... both value and volume terms in 2012 due to increasing demand for lactose-free food and diabetic food. The most widely available ... knowledge. Better living conditions led to an increasing... Euromonitor International's Food Intolerance in China report tracks the developments of health-associated product types ...

... these products which greatly improved their availability and selection. In Norway, food intolerance products were normally available in special health shops, where ... types and the healthy-option positioning of competing brands across different food sectors. It provides the latest retail sales data 2008-2012, ...

... from 2013-2023. The report will be valuable to those already involved in the dermatology market or to those wishing to enter this important market in the future. The Global Dermatology Market 2013-2023 report ...

... are not well-known among local consumers. Nonetheless, the most significant development in food intolerance has come from gluten-free ... is more widely recognised as small babies often... Euromonitor International's Food Intolerance in Ukraine report tracks the developments of health-associated product types ...

... to make it more accessible to patients. According to the “US Proton Therapy Outlook 2017” by RNCOS, the United States will be home to almost 27 such centers ... will breach the Billion dollar mark to attain revenue of US$ 1.17 Billion by 2017. The following 65 pages report provides an insight into the cancer ...

... food. Not only people who are gluten or lactose intolerant purchase such products. Gluten- and lactose-free products are more widely consumed as healthy and weight management options. Euromonitor International's Food Intolerance in Bulgaria report tracks the developments of health-associated product types ...